{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:18:01Z","timestamp":1788826681240,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR27895\/MED\/29\/1270\/2018"],"award-info":[{"award-number":["BT\/PR27895\/MED\/29\/1270\/2018"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bioorg.2021.105288","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T10:50:51Z","timestamp":1629370251000},"page":"105288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Synthesis and antibacterial evaluation of (E)-1-(1H-indol-3-yl) ethanone O-benzyl oxime derivatives against MRSA and VRSA strains"],"prefix":"10.1016","volume":"116","author":[{"given":"Ravikumar","family":"Akunuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Veerareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Akhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer","family":"Unnissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramulu","family":"Parupalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.V.","family":"Madhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bioorg.2021.105288_b0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathogens and Global Health."},{"key":"10.1016\/j.bioorg.2021.105288_b0010","unstructured":"(a) Health matters: antimicrobial resistance, GOV.UK, n.d. (accessed April 21, 2021). (b) New antimicrobials | DEINOVE, n.d. (accessed April 21, 2021)."},{"key":"10.1016\/j.bioorg.2021.105288_b0015","unstructured":"C.D.| N.R.| C.N.| Nov 26, 2019, CDC: Medical devices key source of antibiotic-resistant infections, CIDRAP, n.d. (accessed April 21, 2021)."},{"key":"10.1016\/j.bioorg.2021.105288_b0020","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J Clin Invest."},{"key":"10.1016\/j.bioorg.2021.105288_b0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejmech.2017.04.003","article-title":"Indoles as therapeutics of interest in medicinal chemistry: Bird\u2019s eye view","volume":"134","author":"Chadha","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105288_b0030","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.3390\/molecules18066620","article-title":"Biomedical Importance of Indoles","volume":"18","author":"Kaushik","year":"2013","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.bioorg.2021.105288_b0035","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.bmcl.2010.04.137","article-title":"Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus","volume":"20","author":"Al-Qawasmeh","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105288_b0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ejmech.2018.03.031","article-title":"Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria","volume":"150","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2021.105288_b0045","doi-asserted-by":"crossref","first-page":"9712","DOI":"10.1021\/acs.jmedchem.5b01482","article-title":"Structure-Activity Relationships of Novel Tryptamine-Based Inhibitors of Bacterial Transglycosylase","volume":"58","author":"Sosi\u010d","year":"2015","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2021.105288_b0050","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1016\/j.bmc.2012.10.002","article-title":"Optimization and structure\u2013activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents","volume":"20","author":"Kumar","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105288_b0055","unstructured":"Drug Approval Package: Factive (Gemifloxacin Mesylate) NDA #021158, n.d. (accessed April 21, 2021)."},{"key":"10.1016\/j.bioorg.2021.105288_b0060","unstructured":"Drug Approval Package: Spectracef (Cefditoren Pivoxil) NDA #21-222<, n.d. (accessed April 21, 2021)."},{"key":"#cr-split#-10.1016\/j.bioorg.2021.105288_b0065.1","doi-asserted-by":"crossref","unstructured":"(a) J. Heeres, L. Meerpoel, P. Lewi, Conazoles, Molecules 15 (2010) 4129-4188.","DOI":"10.3390\/molecules15064129"},{"key":"#cr-split#-10.1016\/j.bioorg.2021.105288_b0065.2","doi-asserted-by":"crossref","unstructured":"(b) A.Z. Shyadehi, D.C. Lamb, S.L. Kelly, D.E. Kelly, W.-H. Schunck, J.N. Wright, D. Corina, M. Akhtar, The mechanism of the acyl-carbon bond cleavage reaction catalyzed by recombinant sterol 14\u03b1-demethylase of Candida albicans (Other Names Are: Lanosterol 14\u03b1-Demethylase, P-45014DM, and CYP51), J. Biol. Chem. 271 (1996) 12445-12450.","DOI":"10.1074\/jbc.271.21.12445"},{"key":"#cr-split#-10.1016\/j.bioorg.2021.105288_b0065.3","doi-asserted-by":"crossref","unstructured":"(c) L. Milanese, N. Giacch\u00e8, F. Schiaffella, A. Vecchiarelli, A. Macchiarulo, R. Fringuelli, Oxime and oxime ether derivatives of 1,4-benzothiazine related to oxiconazole, ChemMedChem 2 (2007) 1208-1213.","DOI":"10.1002\/cmdc.200700066"},{"issue":"34","key":"10.1016\/j.bioorg.2021.105288_b0070","doi-asserted-by":"crossref","first-page":"21929","DOI":"10.1021\/acsomega.0c03207","article-title":"Repurposing Clinically Approved Drugs for the Treatment of \u201cBacillus cereus\u201d, a Surrogate for Bacillus anthracis, ACS","volume":"5","author":"Amakawa","year":"2020","journal-title":"Omega"},{"issue":"6","key":"10.1016\/j.bioorg.2021.105288_b0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ejmech.2006.02.005","article-title":"Synthesis, stereochemistry, and antimicrobial evaluation of substituted piperidin-4-one oxime ethers","volume":"41","author":"Ramalingan","year":"2006","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105288_b0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejmech.2012.08.022","article-title":"Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine","volume":"56","author":"White","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105288_b0085","unstructured":"Clinical and Laboratory Standards Institute (Ed.), Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: M07-A10\u00a0; approved standard, 10th ed., Committee for Clinical Laboratory Standards, Wayne, PA, 2015."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105288_b0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/510431","article-title":"New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria","volume":"44","author":"Jorgensen","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"#cr-split#-10.1016\/j.bioorg.2021.105288_b0095.1","doi-asserted-by":"crossref","unstructured":"(a) M. Pandey, A.K. Singh, R. Thakare, S. Talwar, P. Karaulia, A. Dasgupta, S. Chopra, A.K. Pandey, Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity, Sci. Rep. 7 (2017) 11521.","DOI":"10.1038\/s41598-017-11575-5"},{"key":"#cr-split#-10.1016\/j.bioorg.2021.105288_b0095.2","doi-asserted-by":"crossref","unstructured":"(b) I. Wiegand, K. Hilpert, R.E.W. Hancock, Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances, Nat. Protoc. 3 (2008) 163-175.","DOI":"10.1038\/nprot.2007.521"},{"issue":"2","key":"10.1016\/j.bioorg.2021.105288_b0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis","volume":"41","author":"Rivas-Santiago","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bioorg.2021.105288_b0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejmech.2019.04.067","article-title":"Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis","volume":"175","author":"Gatadi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105288_b0110","article-title":"In-Vitro cytotoxicity activity of Solanum Nigrum extract against Hela cell line and Vero cell line","volume":"1","author":"Patel","year":"2008","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2021.105288_b0115","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph13a08s50","article-title":"Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discovery","author":"Kwasny","year":"2010","journal-title":"Curr. Protoc. Pharmacol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821006659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821006659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:54:58Z","timestamp":1777463698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821006659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":26,"alternative-id":["S0045206821006659"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105288","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and antibacterial evaluation of (E)-1-(1H-indol-3-yl) ethanone O-benzyl oxime derivatives against MRSA and VRSA strains","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105288"}}